Advertisement
UK markets closed

  • FTSE 100

    8,317.59
    -21.64 (-0.26%)
     

  • FTSE 250

    20,770.93
    +139.63 (+0.68%)
     

  • AIM

    810.02
    +5.00 (+0.62%)
     

  • GBP/EUR

    1.1760
    +0.0023 (+0.19%)
     

  • GBP/USD

    1.2770
    +0.0031 (+0.25%)
     

  • Bitcoin GBP

    54,689.63
    +781.64 (+1.45%)
     

  • CMC Crypto 200

    1,505.42
    +21.22 (+1.43%)
     

  • S&P 500

    5,304.72
    +36.88 (+0.70%)
     

  • DOW

    39,069.59
    +4.29 (+0.01%)
     

  • CRUDE OIL

    78.55
    +0.83 (+1.07%)
     

  • GOLD FUTURES

    2,352.50
    +18.00 (+0.77%)
     

  • NIKKEI 225

    38,900.02
    +253.91 (+0.66%)
     

  • HANG SENG

    18,827.35
    +218.41 (+1.17%)
     

  • DAX

    18,774.71
    +81.34 (+0.44%)
     

  • CAC 40

    8,132.49
    +37.52 (+0.46%)
     

FMC would look at Diaverum if it was put up for sale - CEO

Reuters - UK Focus

BAD HOMBURG, Germany Feb 25 (Reuters) - Fresenius Medical Care, the world's biggest provider of dialysis treatments, would look at Swedish rival Diaverum if it was for sale, its chief executive said.

"We would look at that," Rice Powell told Reuters in an interview after FMC (NYSE: FMC - news) published 2013 financial results on Tuesday.

Diaverum's owner, private equity firm Bridgepoint, has been looking to offload the Swedish dialysis clinic operator, which could fetch more than 1 billion euros ($1.37 billion).